Gastrointestinal Cancer-Refresher 2017
The first session will provide a clinical update on the optimal management of upper GI malignancies including esophageal cancer, gastric cancer and pancreatic cancer. The focus will be on combined modality management of these diseases with an emphasis on clinical evidence for the use of radiotherapy. Radiotherapy techniques will be discussed depending on the relevance to each disease site. Controversies in the field and best clinical practices will also be addressed.
The second session focuses on lower gastrointestinal multi-modality treatment employing chemoradiation which remains the standard of care for locally advanced anal and rectal cancers. However, despite overall high pelvic control rates, this management strategy comes at a price in terms of toxicity and cost. While some of this morbidity may be ameliorated with advanced radiation technologies (such as IMRT), personalized risk-stratified treatments are still warranted to provide optimal outcomes and minimized toxicity for our patients.
This activity is available from September 14, 2017, through 11:59 p.m. Eastern time on September 13, 2020.
This activity was originally recorded at ASTRO’s 2017 Refresher, April 7-9, 2017 in Chicago, IL.
This program is designed to meet the interest of radiation oncologists, radiation therapists, and radiation dosimetrists.
Upon completion of the upper GI activity, participants should be able to:
- Describe treatment options for patients with esophageal cancer.
- Discuss treatment options for patients with gastric cancer.
- Identify treatment options for patients with pancreatic cancer.
Upon completion of the lower GI activity, participants should be able to:
- Demonstrate knowledge of the evidence-based rationale for the use of definitive chemoradiation in localized anal canal cancer and preoperative chemoradiation for localized rectal cancer.
- Discuss the novel strategies, including IMRT for anal cancer and the selective use of radiation in rectal cancer, to optimize treatment outcomes and reduce treatment-related morbidity.
- Identify ongoing and future investigations aimed at individualizing therapy.
- Albert Koong, MD, is employed at Stanford University and has no financial relationships with a commercial interest.
- Lisa Kachnic, MD, FASTRO, is employed by Vanderbilt University, receives compensation from UpToDate, NCI NCORP, SWOG. and holds a leadership position at ABR.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $105
- Member: $55
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.